Table 1.
Entry demography of the 41 patients of this study
| GMA | PSL | ||
|---|---|---|---|
|
Gender: |
Male/Female |
14/10 |
7/10 |
|
Mean age (range) |
|
33.6(15–78) |
35.4(13–65) |
|
Extent of UC |
Total |
17 |
10 |
| |
Left sided |
6 |
5 |
| |
Recto-sigmoid |
1 |
2 |
|
Clinical course |
Chronic continuous type |
0 |
1 |
| |
Relapsing remitting type |
28 |
14 |
| |
First UC episode |
0 |
2 |
|
Inpatient/Outpatient |
|
19/5 |
17/0 |
|
Patients with a history of exposure to PSL |
|
17 |
13 |
| Patients on AZA (50mg/day) | 8 | 8 |
GMA, adsorptive granulocyte and monocyte apheresis; PSL, predonisolone; AZA, azathioprine (started ≥8 weeks ahead of entry).
All patients were included following a relapse of ulcerative colitis (UC)